Ignite Creation Date:
2024-07-17 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06488924
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-28
Brief Title:
An Open-label Phase III Study of JR-446 in Mucopolysaccharidosis Type IIIB
Sponsor:
JCR Pharmaceuticals Co Ltd
Organization:
JCR Pharmaceuticals Co Ltd
Study Overview
Official Title:
An Open-label Phase III Study of JR-446 in Mucopolysaccharidosis Type IIIB
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Phase I II open-label study designed to evaluate the safety and explore efficacy of the study drug in development for the treatment of MPS IIIB patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None